Article
Venous and arterial thrombosis in patients with VEXAS syndrome.
Blood - 23 May 2024
Kusne Yael, Ghorbanzadeh Atefeh, Dulau-Florea Alina, Shalhoub Ruba, Alcedo Pedro E, Nghiem Khanh, Ferrada Marcela A, Hines Alexander, Quinn Kaitlin A, Panicker Sumith R, Ombrello Amanda K, Reichard Kaaren, Darden Ivana, Goodspeed Wendy, Durrani Jibran, Wilson Lorena, Olteanu Horatiu, Lasho Terra, Kastner Daniel L, Warrington Kenneth J, Mangaonkar Abhishek, Go Ronald S, Braylan Raul C, Beck David B, Patnaik Mrinal M, Young Neal S, Calvo Katherine R, Casanegra Ana I, Grayson Peter C, Koster Matthew J, Wu Colin O, Kanthi Yogendra, Patel Bhavisha A, Houghton Damon E, Groarke Emma M
Abstract excerpt
ABSTRACT: VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome, caused by somatic mutations in UBA1, is an autoinflammatory disorder with diverse systemic manifestations. Thrombosis is a prominent clinical feature of VEXAS syndrome. The risk factors and frequency of thrombosis in VEXAS syndrome are not well described, due to the disease's recent discovery and the paucity of large databases....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
